Advances in spatial multi-omics in tumors

2024-8-26

Implementation of a MSRE ddPCR method for the detection of methylated <i>WIF1</i> and <i>NPY</i> genes in colorectal cancer patients

2024-8-5

Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease

2024-8-2

Personalized treatment using predictive biomarkers in solid organ malignancies: A review

2024-8-2

Quality assurance for cancer patient safety: Clinical assessment for precise angles in linac during radiation therapy

2024-8-2

Italian translation, cultural adaptation and pilot testing of Psychosocial Assessment Tool (PAT 3.1) in pediatric cancer

2024-7-30

Multiple targets, germline <i>BRCA1</i> mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making

2024-6-13

North-south differences in incidence and surveillance of cutaneous malignant melanoma in Italy

2024-6-2

Efficacy and safety of induction chemotherapy in oral cavity cancer: An eight-year experience at a Portuguese reference center

2024-6-2

Effect of neoadjuvant chemoradiation on anorectal function assessed with anorectal manometry: A systematic review and meta-analysis

2024-5-31

In reply to Topkan et al

2024-5-27

A case series of non-small cell lung cancer patients with <i>EGFR</i> or <i>HER2</i> exon 20 insertion in Li Fraumeni syndrome

2024-5-23

Dosimetric and NTCP analyses for selecting parotid gland cancer patients for proton therapy

2024-5-21

Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy?

2024-5-15

Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer

2024-5-10

Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available?

2024-5-10

PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials

2024-4-27

Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs

2024-4-16

The digital revolution in pathology: Towards a smarter approach to research and treatment

2024-4-12

The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers

2024-4-9

A five-year review of chemoradiotherapy practice in anal cancer: Radiotherapy audit results from a cancer centre in Wales, UK

2024-3-29

Response to Deantoni et al.

2024-3-12

Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey

2024-3-10

Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments

2024-2-19

How many Italian cancer patients are eligible for, and may respond to, Italian Medicines Agency-approved immune checkpoint inhibitors?

2024-2-19

Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund

2024-2-19

The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)

2024-2-7

Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance

2024-2-5

bgicc 2024 abstracts

2024-2-1

Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report

2024-1-5

Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis

2024-1-5

Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach

2024-1-5

A new era after a long wait: Vorasetinib, an inhibitor of mutant IDH1 and IDH2 enzymes in patients with IDH-mutant glioma

2024-1-2

Cytisine as a smoking cessation aid: Preliminary observations with a modified therapeutic scheme in real life

2023-12-27

A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval

2023-12-23

Adjuvant treatment in hormone receptor-positive early breast cancer: New approaches of endocrine therapy

2023-12-19

Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case report

2023-12-1

I was only sixteen

2023-11-30

HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination

2023-11-17

Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience

2023-11-17

Management of primary and recurrent Bartholin’s gland carcinoma: A systematic review on behalf of MITO Rare Cancer Group

2023-11-13

A shared vaccination ambulatory for patients with cancer in Udine, Italy

2023-10-30

A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy

2023-10-26

Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort

2023-10-11

AIOM Abstract

2023-10-1

Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting

2023-9-29

PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey

2023-9-19

De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?

2023-9-11

Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study

2023-9-9

There is no such a thing as a ‘<i>biological</i>’ basis for cancer disparities: A call to end misreporting of the ultimate determinants of health outcomes

2023-9-9